SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 246 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $335,000 | -69.9% | 1,942 | -80.3% | 0.00% | -50.0% |
Q4 2014 | $1,114,000 | -58.1% | 9,846 | -42.2% | 0.00% | -60.0% |
Q3 2014 | $2,661,000 | +39.6% | 17,029 | +18.1% | 0.01% | +66.7% |
Q2 2014 | $1,906,000 | +290.6% | 14,423 | +205.2% | 0.00% | +200.0% |
Q1 2014 | $488,000 | -50.1% | 4,725 | -52.9% | 0.00% | -50.0% |
Q4 2013 | $977,000 | -8.3% | 10,031 | -37.1% | 0.00% | 0.0% |
Q3 2013 | $1,066,000 | -69.7% | 15,948 | -70.0% | 0.00% | -66.7% |
Q2 2013 | $3,514,000 | – | 53,121 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |